On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC). The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.
Sharma, A., Sangiolo, D., Rosato, A., Pu, J., Hou, J., Tettamanti, S., et al. (2025). Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 74(12) [10.1007/s00262-025-04216-8].
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches
Tettamanti S.;Serafini M.;Introna M.;Rambaldi A.;
2025
Abstract
On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC). The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Sharma et al-2025-Cancer Immunol Immunother-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
692.52 kB
Formato
Adobe PDF
|
692.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
